# Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

> **NCT04617457** · PHASE2 · UNKNOWN · sponsor: **University of Cologne** · enrollment: 150 (estimated)

## Conditions studied

- Pancreatic Cancer
- Metastasis
- Surgery
- Oligometastatic Disease

## Interventions

- **DRUG:** nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)

## Key facts

- **NCT ID:** NCT04617457
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04617457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04617457, "Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04617457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*